Shivom - A Blockchain Based Genomics and Healthcare Platform

The healthcare world is changing and medicine becomes more personalized, which is why there is no need to accept old medical treatments and risk proper health. Nowadays, skillful developers try to combine genomics and blockchain, which are two revolutionary technologies, in order to achieve a significant improvement in medical care and well-being throughout the world.

Shivom presents a blockchain-based genomic data hub, which will join patients, medical specialists, genome data donors and different pharmacists into a unified support environment, where interested individuals will be enabled to contribute their DNA sample and obtain their genome sequenced and safely kept for any future personal usage. The platform will provide an open marketplace for medical care suppliers to introduce various apps and services along with genomic data analytics and personalized medicine. This will ensure:

• sponsorship of sequencing projects to obtain accessibility to appropriate information
• break down of data silos
• transformation of genomic data into useful information
• simplification of drug studies and improvement
• assistance in diverse clinical trials

Shivom aims to develop the direct-to-customer business and make it profitable to any interested party. The platform creates a disruptive genomics ecosystem, which guarantees that data is owned by data donors, and if they choose to share it, then they will be able to track where and by whom the information is used. In such a way:

• patients have direct insight into their health risks, receive better medical treatment, receive personalized medical care, well-being and lifestyle information
• genomic data donors own their data and access rights to it
• contributors can obtain rewards for sharing their genomic information by selling the accessibility to middleman institutions like pharmaceutical enterprises
• the platform members possess complete control of who can access their data even when the middleman institutions got the accessibility to it

It should also be mentioned that by applying the most advanced technologies such as genome sequencing, blockchain, artificial intelligence, big data analytics and computing, Shivom would bring medical genomics to a higher level of development. By introducing cryptography technology, Shivom database will ensure confidentiality, transparent and safe information, and by using blockchain technology, it will provide its accuracy with data kept in a decentralized manner and secure user's information against hacking.

Summarizing the above, one can conclude that Shivom focuses on creating the largest genomic data hub, where contributors will share their DNA data and get rewards via Shivom tokens (or OmiX), while pharmaceutical institutions will get direct accessibility to DNA data of every person, who decided to share it, and will be able to increase the drug development and personalize genomics and healthcare data of the donor. Thus, both parties will be in an advantageous position.

Authored By: x0r2